Literature DB >> 9282387

Economic costs and trade impacts of microbial foodborne illness.

J C Buzby, T Roberts.   

Abstract

This article presents the economic costs of foodborne diseases for selected countries, the approaches used to calculate these costs, and a discussion on the interaction between microbial food safety issues and international trade in food. The human illness costs due to foodborne pathogens are estimated most completely in the United States of America, where, each year, 7 foodborne pathogens (Campylobacter jejuni, Clostridium perfringens, Escherichia coli O157:H7. Listeria monocytogenes, Salmonella, Staphylococcus aureus, and Toxoplasma gondii) cause an estimated 3.3-12.3 million cases of foodborne illness and up to 3900 deaths. These 7 pathogens are found in animal products and cost the United States an estimated $6.5-$34.9 billion (1995 US$) annually. The presence of foodborne pathogens in a country's food supply not only affects the health of the local population, but also represents a potential for spread to pathogens to visitors to the country and to consumers in countries which import food products. With more complete data on foodborne illnesses, deaths, costs and international trade rejections in each country, indicators could be developed by which changes in food safety can be monitored.

Entities:  

Mesh:

Year:  1997        PMID: 9282387

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  38 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Estimating the burden and cost of infectious intestinal disease in the Maltese community.

Authors:  C Gauci; H Gilles; S O'Brien; J Mamo; I Stabile; F M Ruggeri; N Calleja; G Spiteri
Journal:  Epidemiol Infect       Date:  2007-02-21       Impact factor: 2.451

3.  Rectoanal junction colonization of feedlot cattle by Escherichia coli O157:H7 and its association with supershedders and excretion dynamics.

Authors:  Rowland N Cobbold; Dale D Hancock; Daniel H Rice; Janice Berg; Robert Stilborn; Carolyn J Hovde; Thomas E Besser
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

4.  The burden of acute gastrointestinal illness in Ontario, Canada, 2005-2006.

Authors:  J M Sargeant; S E Majowicz; J Snelgrove
Journal:  Epidemiol Infect       Date:  2007-06-13       Impact factor: 2.451

Review 5.  Novel approaches for Campylobacter control in poultry.

Authors:  Jun Lin
Journal:  Foodborne Pathog Dis       Date:  2009-09       Impact factor: 3.171

Review 6.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Authors:  Andrew J Neville; Sydney J Zach; Xiaofang Wang; Joshua J Larson; Abigail K Judge; Lisa A Davis; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

7.  Characterization of Salmonella associated with pig ear dog treats in Canada.

Authors:  C Clark; J Cunningham; R Ahmed; D Woodward; K Fonseca; S Isaacs; A Ellis; C Anand; K Ziebell; A Muckle; P Sockett; F Rodgers
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

8.  Origin Detection During Food-borne Disease Outbreaks - A Case Study of the 2011 EHEC/HUS Outbreak in Germany.

Authors:  Juliane Manitz; Thomas Kneib; Martin Schlather; Dirk Helbing; Dirk Brockmann
Journal:  PLoS Curr       Date:  2014-04-01

9.  Evidence for phenotypic plasticity among multihost Campylobacter jejuni and C. coli lineages, obtained using ribosomal multilocus sequence typing and Raman spectroscopy.

Authors:  Daniel S Read; Dan J Woodcock; Norval J C Strachan; Kenneth J Forbes; Frances M Colles; Martin C J Maiden; Felicity Clifton-Hadley; Anne Ridley; Ana Vidal; John Rodgers; Andrew S Whiteley; Samuel K Sheppard
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

10.  Molecular characterization of Campylobacter jejuni clones: a basis for epidemiologic investigation.

Authors:  Kate E Dingle; Frances M Colles; Roisin Ure; Jaap A Wagenaar; Birgitta Duim; Frederick J Bolton; Andrew J Fox; David R A Wareing; Martin C J Maiden
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.